Sun Pharma's Q3 Net Profit Rises 15% to ₹2,903.4 Crore

Sun Pharmaceutical Industries Ltd has reported a 15% year-on-year increase in consolidated net profit, reaching ₹2,903.4 crore for the quarter ended December 31, 2024. This growth aligns with market expectations.

The company's total revenue for the quarter stood at ₹13,675 crore, slightly surpassing the estimated ₹13,422 crore. Net profit also exceeded projections, coming in at ₹2,903.4 crore against an expected ₹2,881 crore.

This performance underscores Sun Pharma's robust position in the pharmaceutical industry, driven by its diverse product portfolio and strategic market initiatives.

Source: ndtvprofit.com